跳至主要内容
临床试验/NCT04280926
NCT04280926已完成不适用

Use of High Sensitivity Cardiac Troponin in Safely Ruling Out Emergency Patients with Acute Myocardial Injury and Infarction (SAFETY)

Hennepin Healthcare Research Institute1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2020年10月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,000
试验地点
1
主要终点
Incidence of acute myocardial infarction - Abbott hs-cTnI

研究概览

简要总结

Examine the analytical and clinical performance of Atellica IM TnIH assay for the diagnosis and rule out of acute myocardial injury and myocardial infarction in patients presenting to the emergency department in whom serial cTnI measurements are obtained on clinical indication.

详细描述

Background: Studies addressing the clinical performance of the Siemens Healthineers High-Sensitivity Troponin I assay (TnIH) on the Atellica IM analyzer for the diagnosis and rule out of acute myocardial injury and myocardial infarction in consecutive patients presenting to a United States (US) emergency department are lacking.

Study objective: Examine the analytical and clinical performance of Atellica IM TnIH assay for the diagnosis and rule out of acute myocardial injury and myocardial infarction in patients presenting to the emergency department in whom serial cTnI measurements are obtained on clinical indication.

Hypothesis

The Atellica IM TnIH assay will offer an excellent diagnostic performance for acute myocardial injury and acute myocardial infarction, as well as expedite the risk stratification of patients for early discharge from the emergency department.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Baseline cTn measurement and at least one additional cTn measurement within 6 hours after initial measurement.
  • At least one 12-lead electrocardiogram

排除标准

  • Less than 18 years old
  • Decline to participate
  • Did not present through the ED
  • Transferred from an outside hospital or clinic.

结局指标

主要结局

Incidence of acute myocardial infarction - Abbott hs-cTnI

时间窗: Day 1

Adjudicated diagnosis of acute myocardial injury using the Abbott hs-cTnI assay

Incidence of myocardial infarction - Roche Gen 5 cTnT

时间窗: Day 1

Adjudicated diagnosis of acute myocardial injury using the Roche Gen 5 cTnT assay

Incidence of myocardial infarction - Abbott contemporary cTnI

时间窗: Day 1

Adjudicated diagnosis of acute myocardial injury using the Abbott contemporary cTnT assay

次要结局

  • Number of participants that underwent revascularization(up to 180 days)
  • All-cause mortality(up to 180 days)
  • Adjudicated index acute myocardial infarction according to 4th UDMI(on admission)
  • Cardiac mortality(up to 180 days)
  • Safety Outcome - MACE(180 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验